BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29915212)

  • 1. Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment.
    Koh K; Ishiura H; Beppu M; Shimazaki H; Ichinose Y; Mitsui J; Kuwabara S; Tsuji S; Takiyama Y;
    J Hum Genet; 2018 Sep; 63(9):1009-1013. PubMed ID: 29915212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Δ
    Marco-Marín C; Escamilla-Honrubia JM; Llácer JL; Seri M; Panza E; Rubio V
    J Inherit Metab Dis; 2020 Jul; 43(4):657-670. PubMed ID: 32017139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPG9A with the new occurrence of an ALDH18A1 mutation in a CMT1A family with PMP22 duplication: case report.
    Koh K; Takaki R; Ishiura H; Tsuji S; Takiyama Y
    BMC Neurol; 2021 Feb; 21(1):64. PubMed ID: 33573605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Compound Missense and Intronic Splicing Mutation in
    Chen YJ; Zhang ZQ; Wang MW; Qiu YS; Yuan RY; Dong EL; Zhao Z; Zhou HT; Wang N; Chen WJ; Lin X
    Front Neurol; 2021; 12():627531. PubMed ID: 34093392
    [No Abstract]   [Full Text] [Related]  

  • 5. P5CS expression study in a new family with ALDH18A1-associated hereditary spastic paraplegia SPG9.
    Magini P; Marco-Marin C; Escamilla-Honrubia JM; Martinelli D; Dionisi-Vici C; Faravelli F; Forzano F; Seri M; Rubio V; Panza E
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1533-1540. PubMed ID: 31402623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tremor as an early sign of hereditary spastic paraplegia due to mutations in ALDH18A1.
    Kalmár T; Maróti Z; Zimmermann A; Sztriha L
    Brain Dev; 2021 Jan; 43(1):144-151. PubMed ID: 32798076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia.
    Coutelier M; Goizet C; Durr A; Habarou F; Morais S; Dionne-Laporte A; Tao F; Konop J; Stoll M; Charles P; Jacoupy M; Matusiak R; Alonso I; Tallaksen C; Mairey M; Kennerson M; Gaussen M; Schule R; Janin M; Morice-Picard F; Durand CM; Depienne C; Calvas P; Coutinho P; Saudubray JM; Rouleau G; Brice A; Nicholson G; Darios F; Loureiro JL; Zuchner S; Ottolenghi C; Mochel F; Stevanin G
    Brain; 2015 Aug; 138(Pt 8):2191-205. PubMed ID: 26026163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compound heterozygous mutations in two different domains of ALDH18A1 do not affect the amino acid levels in a patient with hereditary spastic paraplegia.
    Steenhof M; Kibæk M; Larsen MJ; Christensen M; Lund AM; Brusgaard K; Hertz JM
    Neurogenetics; 2018 Aug; 19(3):145-149. PubMed ID: 29754261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel CAPN1 mutations extend the phenotypic heterogeneity in combined spastic paraplegia and ataxia.
    Lai LL; Chen YJ; Li YL; Lin XH; Wang MW; Dong EL; Wang N; Chen WJ; Lin X
    Ann Clin Transl Neurol; 2020 Oct; 7(10):1862-1869. PubMed ID: 32860341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation.
    Nielsen JE; Johnsen B; Koefoed P; Scheuer KH; Grønbech-Jensen M; Law I; Krabbe K; Nørremølle A; Eiberg H; Søndergård H; Dam M; Rehfeld JF; Krarup C; Paulson OB; Hasholt L; Sørensen SA
    Eur J Neurol; 2004 Dec; 11(12):817-24. PubMed ID: 15667412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia.
    Coarelli G; Romano S; Travaglini L; Ferraldeschi M; Nicita F; Spadaro M; Fornasiero A; Frontali M; Salvetti M; Bertini E; Ristori G
    Clin Neurol Neurosurg; 2018 May; 168():60-63. PubMed ID: 29524657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autosomal-recessive complicated spastic paraplegia with a novel lysosomal trafficking regulator gene mutation.
    Shimazaki H; Honda J; Naoi T; Namekawa M; Nakano I; Yazaki M; Nakamura K; Yoshida K; Ikeda S; Ishiura H; Fukuda Y; Takahashi Y; Goto J; Tsuji S; Takiyama Y
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1024-8. PubMed ID: 24521565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply: ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism.
    Coutelier M; Mochel F; Saudubray JM; Ottolenghi C; Stevanin G
    Brain; 2016 Jan; 139(Pt 1):e4. PubMed ID: 26297557
    [No Abstract]   [Full Text] [Related]  

  • 14. ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism.
    Panza E; Escamilla-Honrubia JM; Marco-Marín C; Gougeard N; De Michele G; Morra VB; Liguori R; Salviati L; Donati MA; Cusano R; Pippucci T; Ravazzolo R; Németh AH; Smithson S; Davies S; Hurst JA; Bordo D; Rubio V; Seri M
    Brain; 2016 Jan; 139(Pt 1):e3. PubMed ID: 26297558
    [No Abstract]   [Full Text] [Related]  

  • 15. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78).
    Estrada-Cuzcano A; Martin S; Chamova T; Synofzik M; Timmann D; Holemans T; Andreeva A; Reichbauer J; De Rycke R; Chang DI; van Veen S; Samuel J; Schöls L; Pöppel T; Mollerup Sørensen D; Asselbergh B; Klein C; Zuchner S; Jordanova A; Vangheluwe P; Tournev I; Schüle R
    Brain; 2017 Feb; 140(2):287-305. PubMed ID: 28137957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of ganglioside biosynthesis responsible for complex hereditary spastic paraplegia.
    Boukhris A; Schule R; Loureiro JL; Lourenço CM; Mundwiller E; Gonzalez MA; Charles P; Gauthier J; Rekik I; Acosta Lebrigio RF; Gaussen M; Speziani F; Ferbert A; Feki I; Caballero-Oteyza A; Dionne-Laporte A; Amri M; Noreau A; Forlani S; Cruz VT; Mochel F; Coutinho P; Dion P; Mhiri C; Schols L; Pouget J; Darios F; Rouleau GA; Marques W; Brice A; Durr A; Zuchner S; Stevanin G
    Am J Hum Genet; 2013 Jul; 93(1):118-23. PubMed ID: 23746551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel homozygous mutations of CAPN1 in Chinese patients with hereditary spastic paraplegia and literatures review.
    Peng F; Sun YM; Quan C; Wang J; Wu JJ
    Orphanet J Rare Dis; 2019 Apr; 14(1):83. PubMed ID: 31023339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant SPG9: intrafamilial variability and onset during pregnancy.
    Marelli C; Badiou S; Genestet S; Larrieu L; Damier P; Camu W; Planes M; Koenig M; Guissart C
    Neurol Sci; 2020 Jul; 41(7):1931-1933. PubMed ID: 32221810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel De Novo Mutations in KIF1A as a Cause of Hereditary Spastic Paraplegia With Progressive Central Nervous System Involvement.
    Hotchkiss L; Donkervoort S; Leach ME; Mohassel P; Bharucha-Goebel DX; Bradley N; Nguyen D; Hu Y; Gurgel-Giannetti J; Bönnemann CG
    J Child Neurol; 2016 Aug; 31(9):1114-9. PubMed ID: 27034427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary spastic paraplegia: new insights into clinical variability and spasticity-ataxia phenotype, and novel mutations.
    Sahin I; Saat H
    Acta Neurol Belg; 2022 Dec; 122(6):1529-1535. PubMed ID: 34420199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.